Real-World Data Show Trastuzumab Deruxtecan Extends Survival in HER2-Low Metastatic Breast Cancer
A real-world cohort of 126 Chinese patients shows trastuzumab deruxtecan delivers a median 9.1 months of progression-free survival in HER2-low ...
Tag: Progression-Free Survival
A Simple Blood Protein Could Reveal How Aggressive Advanced Prostate Cancer Will Be
Danish researchers report that elevated serum levels of the macrophage-derived protein soluble CD163 independently predict shorter progression-free survival in metastatic ...
Real-World Data Show Antibody-Drug Conjugate Still Works in Late-Stage Triple-Negative Breast Cancer
A multicenter Central European real-world study finds sacituzumab govitecan delivers meaningful survival benefit and manageable toxicity in heavily pretreated metastatic ...
Scarring Lungs Light Up on PET Scans, Hinting at How Deadly Pulmonary Fibrosis Will Become
New research links metabolic activity measured by FDG-PET/CT in scarred lung tissue to clinical severity and hints at faster disease ...
Adding Bevacizumab to Olaparib Boosts Survival Only in BRCA-Mutated Ovarian Cancer
A real-world study of 214 patients finds that adding Bevacizumab to Olaparib maintenance therapy significantly improves overall survival only in ...
Brain Tumor Study Reveals How Much Surgery Matters in Oligodendroglioma
A 277-patient retrospective cohort study finds that gross total resection independently prolongs progression-free survival in molecularly defined oligodendroglioma without increasing ...
Stem Cell Transplant Deepens Myeloma Response, and a Year of MRD Negativity May Signal Lasting Remission
A real-world study of fifty multiple myeloma patients found that high-dose melphalan with autologous stem cell transplantation doubled complete response ...
PET Scan Data Joins Clinical Factors to Predict Relapse in MALT Lymphoma
Researchers in Wuhan have built a prognostic nomogram that combines FDG PET/CT metabolic imaging with clinical and pathological variables to ...
Adding Immunotherapy to Chemo and Bevacizumab Extends Survival in Recurrent Cervical Cancer
A retrospective Chinese study finds that adding the PD-1 inhibitor tislelizumab to paclitaxel-carboplatin chemotherapy and bevacizumab significantly improves response rates, ...
Persistent Emotional Distress Tracks With Poorer Survival in Lung Cancer Patients Undergoing Neoadjuvant Therapy and Surgery
A multicenter study of 167 lung cancer patients found that persistent emotional distress across neoadjuvant therapy and surgery was independently ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!